An overview of the field
Life sciences are a branch of science concerned with the study of living organisms and life processes. An ever developing field and given the demand for innovation in medicine, life science companies are often seeking funding for further research. Thanks to innovations in the investment sphere, there are now many ways for them to go about this task.
According to figures quoted in The Telegraph, early-stage investment into UK life science companies more than tripled between 2015 and 2016. The report goes on to state that despite the instability stemming from the Brexit vote in mid-2016, investment was again expected to increase in 2017.
Life science companies were quick to adopt equity crowdfunding as a means to raise funds. In 2015, SyndicateRoom was named Europe’s leading online platform for life science investment in a report by Biocom, having funded 16 of the 42 life science projects up to that date. Since then, we have continued to support a number of life science companies, in fact, as of June 2017, 31 percent of all fully funded companies on SyndicateRoom specialised in life sciences. Those eager to shape the future of biological research now have many opportunities to invest in a startup within the life science sector. You can view our full portfolio below.
In June 2017, drug company Peptinnovate Limited successfully funded on SyndicateRoom, raising a total of £2,788,130. The company, whose CEO Richard Nagle counts more than 25 years of experience in the pharmaceutical industry, is looking to significantly advance the control and management of moderate to severe chronic inflammatory diseases.
Why invest with SyndicateRoom?
Our Access EIS fund builds a diversified startup portfolio for you by co-investing with experienced angel investors. It aims to build a portfolio of at least 50 companies for each investor to further mitigate risk, and to replicate annual market growth in the UK startup sector.
What SyndicateRoom offers:
A data-driven approach to venture capital investing that aims to minimise risk.
Access to a larger portion of the startup market through co-investment with experienced business angels.
Generous tax reliefs as part of the EIS scheme for qualifying investors.
Low minimum investment of £5,000.
SyndicateRoom is FREE to join
With SyndicateRoom you gain access to invest alongside professional investors receiving the same share class and same share price.